Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2461072A1 Compounds which inhibit the release of inflammatory cytokines
03/27/2003CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2460987A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460719A1 Igf-binding protein-derived peptide or small molecule
03/27/2003CA2460713A1 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
03/27/2003CA2460587A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003CA2460512A1 Thiazolidine derivatives and medicinal use thereof
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460326A1 Method for treating skin disorders
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460319A1 Lpa receptor agonists and antagonists and methods of use
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003CA2460126A1 Tricyclic indole derivatives as 5-ht ligands
03/27/2003CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459547A1 Method of increasing the presence of glutathione in cells
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2457563A1 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/27/2003CA2423885A1 Thiazole and oxazole derivatives
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype
03/26/2003EP1295895A1 Peptides and Protins binding to glu-pro motifs, therapeutical compositions containing them and their applications
03/26/2003EP1295892A1 Antisense molecules and method of controlling expression of gene function by using the same
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295878A1 Novel pyrazinone derivatives
03/26/2003EP1295865A1 Novel dicarboxylic acid derivatives
03/26/2003EP1295609A1 Drugs containing combined active ingredients
03/26/2003EP1295607A1 Antitumor effect potentiators
03/26/2003EP1295604A1 Preventives and remedies for diseases in association with demyelination
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294918A2 Replication deficient adenoviral tnf vector
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294885A2 B7-like molecules and uses thereof
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294873A1 Tumour suppressor and uses thereof
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294868A2 Adenylyl and guanylyl cyclases
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294757A2 Glucagon-like peptide-1 analogs
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
03/26/2003EP1294742A2 Urokinase inhibitors
03/26/2003EP1294741A2 Dipeptide inhibitors for the blood-clotting factor xa
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294729A1 2-aminoalkyl-thieno[2,3-d]pyrimidines
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294723A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294720A1 Non-nucleoside reverse transcriptase inhibitors
03/26/2003EP1294719A1 Melanocortin receptor ligands
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294715A1 Quinazoline ditosylate salt compounds
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294709A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294646A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294406A2 Modulation of chromosome function by chromatin remodeling agents
03/26/2003EP1294405A2 Prodrug compounds cleavable by thimet oligopeptidase
03/26/2003EP1294404A2 Prodrug compounds with an oligopeptide having an isoleucine residue
03/26/2003EP1294403A2 Tripeptide prodrug compounds
03/26/2003EP1294402A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
03/26/2003EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 ... 1564